Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Depressive Mood and Alcohol Use
NCT04498897Phase 2Unknown
- Sponsor
- Hanyang University
- Start
- Jan 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vortioxetine in major depressive disorder (MDD), alcohol use disorder (AUD), sponsored by Hanyang University. Status: unknown.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04498897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498897.